Aetna announced a new collaborative agreement with Community Care Physician Network, LLC (CCPN), to develop innovative ways to transform how health care is delivered in North Carolina. Beginning in January 2018, Aetna will combine its expertise in alternative value-based delivery models with CCPN independent physicians’ advanced medical homes in association with the care management expertise of Community Care of North …

Optim LLC announced it has released a new, next generation LED-based illumination system in its ENTity line of flexible laryngoscopes. “We are happy to announce this key enhancement to our ENTity series of products,” stated Paul Joyce, President and CEO of Optim. “Our innovative flexible laryngoscopes for the ENT provider not only offers the best in health care portability and …

BD announced that its new line of Snowden-Pencer™ 3.0mm laparoscopic ergonomic take-apart instruments received U.S. Food and Drug Administration (FDA) 510(k) clearance for use in laparoscopic surgery. The new line of Snowden-Pencer 3.0mm laparoscopic ergonomic take-apart instruments are designed for micro-laparoscopic surgery and function like 5.0mm instruments. The jaw lengths of the devices mirror those of standard laparoscopic instruments, providing …

RoundTable Healthcare Partners announced that it has made an investment in Deerland Enzymes & Probiotics. Financial terms of the transaction were not disclosed. Deerland Enzymes & Probiotics is a leading developer, formulator, and manufacturer of enzyme- and probiotic-based dietary supplements. The Company is based in Kennesaw, Georgia, where it operates two state-of-the-art manufacturing facilities, including a new, 30,000 square foot …

Stryker Corporation announced a definitive agreement to acquire NOVADAQ Technologies Inc. for US$11.75 per share, or US$701 million with a net purchase price of US$654 million, reflecting net cash of approximately US$47 million. NOVADAQ is a leading developer of fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels, and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, …

PerkinElmer, Inc. announced that it has entered into a definitive agreement to acquire EUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN. The total purchase price of the transaction based on all outstanding shares being acquired will be approximately $1.3 billion in cash. Based in Lübeck, Germany, with approximately 2,400 …

Community Health Systems, Inc. announced that subsidiaries of the Company have signed a definitive agreement to sell five Pennsylvania hospitals and their associated assets to subsidiaries of Reading Health System. Hospitals included in the transaction are 169-bed Brandywine Hospital in Coatesville, 148-bed Chestnut Hill Hospital in Philadelphia, 63-bed Jennersville Hospital in West Grove, 151-bed Phoenixville Hospital in Phoenixville and 232-bed …

Masimo announced FDA 510(k) clearance for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also referred to as tissue or cerebral oximetry, may help clinicians monitor cerebral oxygenation in situations in which peripheral pulse oximetry alone may not be fully indicative of the oxygen in the brain. With the clearance of the O3 pediatric …

Mission Regional Medical Center in Mission, Texas and Prime Healthcare Foundation have signed a definitive agreement for the acquisition of the 297-bed community hospital. The agreement includes a commitment from Prime Healthcare Foundation to maintain Mission Regional as an acute care hospital, strengthen physician recruitment, and to provide a multimillion dollar capital commitment over the next five years. The agreement …

Cerveau Technologies, Inc. announced a research collaboration with the Clinical Imaging Research Centre (CIRC), a joint venture by the Agency for Science, Technology and Research (A*STAR) and the National University of Singapore (NUS), to support various research projects studying the stages of Alzheimer’s Disease and other Neurodegenerative disease. These research projects will utilize an investigational imaging agent (MK-6240) to be …